Repaglinide | EP | Reference Standards | EDQM | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Repaglinide
EDQM

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

Contact Supplier

dmfs-not-supported-m-2025-06-30

granules-india-limited-m-2025-07-07

Contact Supplier

Allsino Pharma excels in R&D & manufacturing of RSMs, GMP intermediates, & APIs; ISO-certified, GMP-compliant, accredited by NMPA.

Contact Supplier

jdmfs-not-supported-m-2025-06-30

Repaglinide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

29 API Suppliers, 12 USDMF, 11 CEP/COS, 3 JDMF, 7 EU WC, 2 KDMF, 6 NDC API, 18 Listed Suppliers, $ API Reference Price

29 API Suppliers
12 USDMF
11 CEP/COS
3 JDMF
7 EU WC
2 KDMF
6 NDC API
18 Listed Suppliers
$ API Reference Price

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

268 FDF Dossiers, 31 FDA Orange Book, 191 Europe, 15 Canada, 6 South Africa, 25 Listed Dossiers

268 FDF Dossiers
31 FDA Orange Book
191 Europe
15 Canada
6 South Africa
25 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 500MG;1MG, TABLET;ORAL - 500MG;2MG

TABLET;ORAL - 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 500MG;1MG
TABLET;ORAL - 500MG;2MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 6 SPI Pharma, 3 DKSH, 5 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 5 Actylis, 1 Aeon Procare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 27 BASF, 1 Corel Pharma Chem, 3 DFE Pharma, 1 Doshion Polyscience, 2 Esteem Industries, 2 Finar, 9 Gangwal Chemicals, 1 Ideal Cures, 3 Ingredion Pharma Solutions, 5 Kerry, 2 Keval Exports, 8 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 25 Roquette, 1 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

48 Fillers, Diluents & Binders, 22 Direct Compression, 20 Disintegrants & Superdisintegrants, 20 Granulation, 20 Solubilizers, 20 Thickeners and Stabilizers, 17 Topical, 16 Co-Processed Excipients, 16 Film Formers & Plasticizers, 16 Lubricants & Glidants, 15 Coating Systems & Additives, 15 Taste Masking, 14 Controlled & Modified Release, 11 Parenteral, 8 Chewable & Orodispersible Aids, 6 Emulsifying Agents, 2 API Stability Enhancers, 2 Coloring Agents, 2 Rheology Modifiers, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

48 Fillers, Diluents & Binders
22 Direct Compression
20 Disintegrants & Superdisintegrants
20 Granulation
20 Solubilizers
20 Thickeners and Stabilizers
17 Topical
16 Co-Processed Excipients
16 Film Formers & Plasticizers
16 Lubricants & Glidants
15 Coating Systems & Additives
15 Taste Masking
14 Controlled & Modified Release
11 Parenteral
8 Chewable & Orodispersible Aids
6 Emulsifying Agents
2 API Stability Enhancers
2 Coloring Agents
2 Rheology Modifiers
1 Soft Gelatin
1 Surfactant & Foaming Agents

DIGITAL CONTENT

8 News #PharmaBuzz

8 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 155 Regulatory FDF Prices, 5 Annual Reports

4 US Medicaid Prescriptions
155 Regulatory FDF Prices
5 Annual Reports

MARKET PLACE

7 APIs, 2 FDF Dossiers

7 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 Health Canada Patents

6 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM

3 EDQM

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 2,490 Xls

Filters

Reset all filters

Filters

FILTER :

filter Order Code Reset all filters

3 All

01 1Y0000457

02 1Y0000458

03 1Y0000459

filter CAS Number Reset all filters

3 All

01 2135062-02-1

02 1147770-08-9

filter Reference Standard Reset all filters

3 All

01 1Repaglinide

02 1Repaglinide for system suitability

03 1Repaglinide impurity E

Product Main Page

01

EDQM, Council of Europe

Repaglinide for system suitability

EPS

Not Confirmed

01

EDQM, Council of Europe

EPS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Repaglinide for system suitability

CAS Number : 135062-02-1

Quantity Per Vial : 6 mg

Sale Unit : 1

Order Code : Y0000458

Batch No : 3

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

EDQM, Council of Europe

Repaglinide impurity E

EPS

Not Confirmed

02

EDQM, Council of Europe

EPS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Repaglinide impurity E

CAS Number : 147770-08-9

Quantity Per Vial : 10 mg

Sale Unit : 1

Order Code : Y0000459

Batch No : 3

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

EDQM, Council of Europe

Repaglinide

EPS

Not Confirmed

03

EDQM, Council of Europe

EPS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Repaglinide

CAS Number : 135062-02-1

Quantity Per Vial : 20 mg

Sale Unit : 1

Order Code : Y0000457

Batch No : 1

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!